Sintx Technologies (SINT) Asset Writedowns and Impairment (2013 - 2026)
Sintx Technologies (SINT) posted Asset Writedowns and Impairment of $9000.0 for Q1 2026, down 85.94% on a QoQ basis from $64000.0 in Q1 2025, and down 85.94% year-over-year from $64000.0 in Q1 2025.
Powered by 
Analysis
Sintx Technologies (SINT) Asset Writedowns and Impairment (2013 - 2026) Analysis & Trends
Sintx Technologies has reported Asset Writedowns and Impairment for 9 years, with the latest figure at $9000.0 in Q1 2026.
- On a quarterly basis, Asset Writedowns and Impairment fell 85.94% year-over-year to $9000.0 in Q1 2026; TTM through Mar 2026 was $9000.0, a 99.81% decrease from a year earlier, with the FY2025 full-year figure at $64000.0, down 98.61% from the prior year.
- Asset Writedowns and Impairment was $9000.0 for Q1 2026 at Sintx Technologies, down from $64000.0 in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $4.5 million in Q3 2024, with the low at -$41000.0 in Q2 2024.
- Average Asset Writedowns and Impairment over 5 years is $583375.0, with a median of $23000.0 recorded in 2024.
- The sharpest annual moves came in 2024 and 2026: Asset Writedowns and Impairment surged 1333.33% in 2024, then plunged 85.94% in 2026.
- Over 5 years, Asset Writedowns and Impairment stood at -$5000.0 in 2022, then soared by 40.0% to -$3000.0 in 2023, then jumped by 4933.33% to $145000.0 in 2024, then plunged by 55.86% to $64000.0 in 2025, then slumped by 85.94% to $9000.0 in 2026.
- The last three Asset Writedowns and Impairment figures came in at $9000.0 (Q1 2026), $64000.0 (Q1 2025), and $145000.0 (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Sintx Technologies | 8.73 Mn | 8.73 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 9,000.00 |
| Mar 31, 2025 | 64,000.00 |
| Dec 31, 2024 | 145,000.00 |
| Sep 30, 2024 | 4.46 Mn |
| Jun 30, 2024 | -41,000.00 |
| Mar 31, 2024 | 37,000.00 |
| Mar 31, 2023 | -3,000.00 |
| Dec 31, 2022 | -5,000.00 |
| Sep 30, 2019 | -12,000.00 |
| Jun 30, 2019 | -75,000.00 |
| Mar 31, 2019 | 84,000.00 |
| Dec 31, 2015 | -20,000.00 |
| Jun 30, 2015 | 13,000.00 |
| Mar 31, 2015 | -20,000.00 |
| Dec 31, 2014 | 27,000.00 |
| Sep 30, 2014 | 58,000.00 |
| Jun 30, 2014 | -3,000.00 |
| Mar 31, 2014 | -17,000.00 |
| Dec 31, 2013 | -97,000.00 |
| Sep 30, 2013 | -79,000.00 |